The U.S. faces “truly daunting” challenges to deploy millions of coronavirus tests to safely re-open the economy, National Institutes of Health Director Francis Collins tells a Senate committee.
National Institutes of Health Director Dr. Francis Collins puts on his face mask after a Senate Health Education Labor and Pensions Committee hearing on new coronavirus tests on Capitol Hill in Washington, Thursday, May 7, 2020.
WASHINGTON — Despite a massive effort, the nation faces “truly daunting” challenges to deploy millions of coronavirus tests to safely re-open the economy, the head of the National Institutes of Health told lawmakers Thursday. NIH Director Francis Collins told the Senate Health, Education, Labor and Pensions committee that government and private industry have launched a $2.5 billion, taxpayer-funded effort to develop, manufacture and distribute technology capable of accurately testing millions of people a week by the end of the summer or the fall, before the annual flu season.to reopening the economy because it would allow public health officials to identify and contain a rebound of the virus. It remains a high bar to clear. “I must tell you, senators, that this is a stretch goal that goes well beyond what most experts think will be possible,” Collins said. “I have encountered some stunned expressions when describing these goals and this timetable to knowledgeable individuals. The scientific and logistical challenges are truly daunting.” Nonetheless, Collins said “the track record of American ingenuity” gives him optimism. More than three months into the epidemic, the lack of testing is widely acknowledged as aThe issue has dogged the White House for weeks. President Donald Trump takes credit for the fact that testing has ramped up dramatically since the early days of the outbreak, when a test from the Centers for Disease Control and Prevention ran into numerous problems.“We do, by far, the most testing,” he told reporters on Wednesday. “If we did very little testing, we wouldn’t have the most cases. So, in a way, by doing all of this testing, we make ourselves look bad.” The U.S. is currently testing more than a million people a week for COVID-19 and White House coronavirus adviser Dr. Deborah Birx has said that weekly number should rise to 2 million or 2.5 million by the middle of June.“To test every nursing home, and every prison, everyone in an operating room, and some entire classes and campuses and factories, teams at sports events, and to give those tests more than once, we will need millions more tests,” agreed committee chairman Sen. Lamar Alexander, R-Tenn. “This demand will only grow as the country goes back to work.” Sen. Patty Murray of Washington, the ranking Democrat on the panel, put the blame on Trump for persistent problems with testing. “The problem isn’t a lack of innovation—it’s a lack of national leadership, and a plan from the White House. “And when it comes to testing, this administration has had no map, and no one at the wheel.” Congress provided NIH with $1.5 billion to develop tests. To help private industry quickly produce and distribute tests that meet NIH standards, lawmakers gave another $1 billion to the Biomedical Advanced Research and Development Authority. Known as BARDA, that agency is under scrutiny after its director alleged he was ousted for opposing widespread use of a a malaria drug promoted by Trump to treat coronavirus patients. Collins said the goal is to have highly accurate tests that can provide quick results at the “point-of-care,” such as a doctor’s office or a community health clinic. A special effort is being made to expand testing in minority communities that have taken the brunt of virus deaths. Many of the currently available tests require processing by a central laboratory to get results. Medical technology giant Abbott already has a point-of-care test available. But Collins said there’s a limited supply of the machines, and that they can sometimes fail to detect a patient who is positive. He said Abbott is working to improve its test, but that he thinks NIH might be able to do better. NIH has set up what Collins calls a “shark tank” process to quickly identify promising technologies, and test them. Within the agency, the initiative is formally called Rapid Acceleration of Diagnostics, or RADx. It was launched just last week. NIH scientists, along with their counterparts in industry and academia, are looking into tests that can use different types of samples, from nasal swabs, saliva, blood, or exhaled breath. They’re also looking at antigen tests that detect a part of the protein capsule of the virus .Associated Press writer Darlene Superville contributed to this report.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Belgian, U.S. scientists look to llama in search for COVID-19 treatmentA llama called Winter could prove useful in the hunt for a treatment for COVID-19, according to U.S. and Belgian scientists who have identified a tiny particle that appears to block the new coronavirus.
Read more »
'A profound danger': Experts warn against broad U.S. reopening amid COVID-19 pandemicAs states lift coronavirus restrictions, none has met federal benchmarks, a health expert warns. The COVID-19 death toll in the U.S. surpasses 73,000.
Read more »
China says supports WHO, opposes U.S., others trying to politicise COVID-19China said on Thursday it supports World Health Organization efforts to investigate the origin of the COVID-19 pandemic, and opposes attempts by the United States and some other countries to politicise the issue and attack Beijing.
Read more »
China says it backs WHO in tracing COVID-19, denounces U.S. 'lies'China said on Thursday it supports the World Health Organization (WHO) in trying to pinpoint the origins of the COVID-19 pandemic and accused U.S. Secretary of State Mike Pompeo of telling one lie after another in his attacks on Beijing.
Read more »
To keep COVID-19 patients home, some U.S. states weigh house arrest techHow do you ensure that someone sick with COVID-19 stays home?
Read more »
U.S. Field Hospitals Stand Down, Most Without Treating Any COVID-19 PatientsThe Army Corps of Engineers began hiring private contractors to build emergency field hospitals in mid-March — an endeavor that cost over $660 million, an NPR analysis of federal spending finds. But most of these facilities haven't seen a single patient.
Read more »